You are here: Industry Insights > patent

News List

Lilly reaches settlement agreement in US Cialis patent litigation cphi-online
July 17, 2017
Cialis exclusivity is now expected to end at the earliest on 27 September 2018.
Humira’s Patent Protection Lawsuit Lost Again, the World’s Top-selling Drug to Gradually Fall off en-cphi.cn
July 14, 2017
In less than two months after Coherus BioSciences succeeded in winning a key intellectual property lawsuit on AbbVie’s Humira, another biological company seeking to launch a biosimilar rival to Humira, a rheumatoid arthritis drug, has scored the same vict
First CRISPR Patent for MilliporeSigma biospectrumasia
June 15, 2017
MilliporeSigma has patent filings for its insertion CRISPR method in Brazil, Canada, China, Europe, India, Israel, Japan, Singapore, South Korea, and the U.S.
Patent library will be founded in Lithuania europeanpharmaceuticalreview
May 26, 2017
The State Patent Bureau of the Republic of Lithuania (SPB) and Kaunas University of Technology National Innovation and Entrepreneurship Centre (KTU NIEC) has signed the collaboration agreement, which laid foundation for the new Patent Library – PATLIB Cen
Soligenix receives Japanese patent pharmaasia
May 25, 2017
The patent is for ThermoVax Vaccine Heat Stabilization Platform Technology
Ocugen expands global patent portfolio for OCU200 pharmasia
May 25, 2017
Company receives patents in US and Japan and notice of intent to grant patent in EU.
US Court of Appeals reverses District Court’s ruling on Aloxi patent pharmaceutical-technology
May 04, 2017
A panel of the United States Court of Appeals for the Federal Circuit has reversed the opinion of the District Court for...
Stainwei Granted Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb americanpharmaceuticalreview
May 04, 2017
Stainwei Biotech announced it received a patent certificate (Patent No. US9,580,498) issued by the United States Patent and Trademark Office for its novel humanized anti-VEGF monoclonal antibody (mAb code name: hPV19).
BioMarin Announces Kuvan Patent Challenge Settlement americanpharmaceuticalreview
April 14, 2017
BioMarin Pharmaceutical Inc. announced it has entered into a settlement agreement with Par Pharmaceutical that resolves patent litigation in the United States (U.S.) related to BioMarin's Kuvan (sapropterin dihydrochloride) 100mg oral tablets and powder f
Court orders Olive Lifesciences to pay Sami-Sabinsa $2.2 million for willful infringement financialexpress
April 12, 2017
The lawsuit alleged that Olive Lifesciences was selling and distributing products that infringed Sami – Sabinsa’s Curcumin C3 Complex Patent

Previous page 1 2 3 4 5 6 Next page